Printer Friendly

Georgian Biomedical Preparations to be Used by a US Owned Company; Bacteriophage-based Antibacterial Products from World-Renowned Eliava Institute to be Used by US Owned Phage Therapy Center in Mexico.

LOS ALTOS, Calif. -- The George Eliava Institute of Bacteriophage, Microbiology and Virology, Republic of Georgia, and Phage International Inc., Los Altos California, announced that they have signed an agreement whereby Eliava will become the supplier of bacteriophages for PII's new Phage Therapy Center in Tijuana Mexico. This is the first commercial use of phages in a medical clinic in the western world and marks a starting point in the promising collaboration between a scientific research center in the Republic of Georgia and a US owned Company. The Institute will test bacterial cultures from PTC patients for PIO-phage susceptibility, produce the appropriate phage and deliver it to PTC to eradicate the bacteria in suffering patients.

"We are delighted that through this cooperation with the Eliava Institute, Phage Therapy Center Mexico will now be able to provide better access to this medical technology," said Ronald Goossens, president PII. "We look forward to making bacteriophage treatments more broadly available in the future".

"The scientists at Eliava Institute are pleased to work with PII in treating patients on the American Continent using our phage preparations and look forward to educating the west on the benefits of bacteriophage technology," said Dr. Teimuraz Chanishvili, Institute Director.

During the 1930's and 40's, bacteriophages were utilized in the United States to treat infections. The use of phages and research were subsequently dropped in the west in favor of antibiotics that became the panacea for treating all infections. The Eliava Institute, however, continued research and development of phage therapeutic technologies. Today bacteriophages represent a viable and effective alternative for fighting drug-resistant infections.

Eliava, an 82 year-old Institute of the Academy of Sciences in the Republic of Georgia, is the world's scientific center for bacteriophage research and development. During the 1970s and 80s the Industrial Branch of the Eliava Institute produced bacteriophage products for military and civilian uses all over the Soviet Union.

Phage Therapy Center Mexico, treats antibiotic-resistant infections and provides treatments that have saved people from amputation.

Phage International, Inc. Los Altos, CA, a primary enabler of phage therapy in the western world, is in the process of opening a number of clinics.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion




Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 18, 2005
Previous Reports: Military Contractors with Excess Cash Create Exciting Opportunities for Investors and Small Companies in the...
Next Article:El Dorado Ventures Names Paul McNamara an Entrepreneur-in-Residence; Former Silicon Graphics Executive Will Focus on Opportunities in...

Related Articles
Biological warfare: scientists once again advocate pitting viruses against bacterial infections.
Cholera hides sinister stowaway.
Inhibit phage attack on starter bacteria.
Viruses that slay bacteria draw new interest.
Viruses stop antibiotic-resistant bacteria. (Science News of the week).
Efficacy and durability of Bacillus anthracis bacteriophages used against spores. (Features).
All the world's a phage: viruses that eat bacteria abound--and surprise.
Phages take breaks while ejecting DNA.
Fisheries Research Agency, Others Isolate Phage that Kills Cyanobacteria.
Salmonella typhimurium DT104, Italy.

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters